Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity

Author： Wasmuth J.-C. Lambertz I. Voigt E. Vogel M. Hoffmann C. Burger D. Rockstroh J.

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.63, Iss.10, 2007-10, pp. : 901-908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Indinavir exposure changes over time in paediatric patients with HIV-1 infection

Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women

By Frost C.E.

Clinical Drug Investigation, Vol. 22, Iss. 2, 2002-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite

Indinavir poorly tolerated in HIV post-exposure prophylaxis

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Optimum doses for regimens of indinavir + ritonavir in HIV

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite